rdf:type |
|
lifeskim:mentions |
umls-concept:C0007320,
umls-concept:C0019829,
umls-concept:C0023449,
umls-concept:C0023866,
umls-concept:C0040715,
umls-concept:C0085973,
umls-concept:C0087111,
umls-concept:C0175668,
umls-concept:C0282443,
umls-concept:C0599718,
umls-concept:C0599813,
umls-concept:C0599893,
umls-concept:C1522702,
umls-concept:C1552617
|
pubmed:issue |
7
|
pubmed:dateCreated |
1991-8-20
|
pubmed:abstractText |
It is apparent that treatment of Hodgkin's disease can be complicated by the development of secondary leukaemia. Most such leukaemias are of the non-lymphocytic type. We describe here a patient treated for Hodgkin's disease with chemo- and radiotherapy who developed secondary acute lymphoblastic leukaemia with a non-random chromosomal abnormality t(4;11). The frequency of such cases is assessed by a literature review and evidence for their pluripotent cell origin is discussed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0887-6924
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
624-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2072750-Adult,
pubmed-meshheading:2072750-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2072750-Chromosomes, Human, Pair 11,
pubmed-meshheading:2072750-Chromosomes, Human, Pair 4,
pubmed-meshheading:2072750-Combined Modality Therapy,
pubmed-meshheading:2072750-Female,
pubmed-meshheading:2072750-Hodgkin Disease,
pubmed-meshheading:2072750-Humans,
pubmed-meshheading:2072750-Leukemia, Radiation-Induced,
pubmed-meshheading:2072750-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:2072750-Translocation, Genetic
|
pubmed:year |
1991
|
pubmed:articleTitle |
Secondary acute lymphoblastic leukaemia with 4:11 translocation following treatment for Hodgkin's disease: case report and review of the literature.
|
pubmed:affiliation |
University Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports,
Research Support, Non-U.S. Gov't
|